Xtant Medical and curasan Enter Distribution Agreement

Xtant Medical entered into a private label distribution agreement with curasan to distribute Matriform synthetic scaffolds in North America.

Matriform, comprising Beta-Tricalcium Phosphate and porcine collagen, allows Xtant to enter the bone graft substitute market. The company's biologic lineup already includes demineralized bone...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us